Does MENATETRENONE Cause Thrombotic microangiopathy? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Thrombotic microangiopathy have been filed in association with MENATETRENONE. This represents 13.9% of all adverse event reports for MENATETRENONE.
5
Reports of Thrombotic microangiopathy with MENATETRENONE
13.9%
of all MENATETRENONE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Thrombotic microangiopathy From MENATETRENONE?
Of the 5 reports, 5 (100.0%) required hospitalization, and 5 (100.0%) were considered life-threatening.
Is Thrombotic microangiopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MENATETRENONE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does MENATETRENONE Cause?
Febrile neutropenia (7)
Adenovirus infection (5)
Diarrhoea (5)
Graft versus host disease (5)
Hepatic function abnormal (5)
Hyperglycaemia (5)
Ileus paralytic (5)
Pneumothorax (5)
Respiratory disorder (5)
What Other Drugs Cause Thrombotic microangiopathy?
TACROLIMUS (1,982)
MYCOPHENOLATE MOFETIL (820)
CYCLOSPORINE (724)
GEMCITABINE (648)
ECULIZUMAB (636)
CYCLOPHOSPHAMIDE (602)
FLUDARABINE (480)
METHOTREXATE (447)
CARFILZOMIB (350)
METHYLPREDNISOLONE (345)